Greg brings extensive experience in the pharmaceutical and biotech sectors both within Australia and internationally. Greg has been involved in the strategic development and commercialisation of a number of products across a range of therapeutic categories.
Throughout his near 20 years working in healthcare Greg has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch critical pathway and commercialisation planning for both domestic and international markets.
As Regional Marketing Lead with Mundipharma International, Greg successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication. Greg has held leadership roles at large multinationals (J&J and CSL) and publicly-listed biotech start-ups.